Merck Group Taiwan yesterday said that it plans to invest substantially on expanding its fab in Kaohsiung’s Lujhu District (路竹) to better serve its local customers, including Taiwan Semiconductor Manufacturing Co (TSMC, 台積電).
The company said it plans to expand its production space by 50 percent in the next five years and its workforce by about 40 percent, Merck Group Taiwan managing director Dick Hsieh (謝志宏) told a media briefing in Taipei.
Hsieh declined to disclose investment details, but said that the latest investment would exceed the total amount Merck has invested in Taiwan over the past few years.
Those investments would be made to address the local semiconductor material market, the largest in the world with a market value of US$11.3 billion last year, Merck said, citing statistics from industrial trade group SEMI.
Taiwan has occupied the top spot for the past 10 years, SEMI said on Tuesday.
Merck has been actively expanding into the semiconductor materials market through acquisitions in recent years, Suresh Rajaraman, senior vice president and business field head of thin film solutions, said yesterday.
The company acquired Versum Materials Inc, an Arizona-based semiconductor materials supplier, in October last year after acquiring special chemical supplier AZ Electronics Materials SA in 2014.
Those acquisitions helped Merck broaden its product portfolio to include the materials, chemicals and gas used in the seven major steps in manufacturing chips, it said.
Merck set up a new lab at its Kaohsiung manufacturing campus soon after its acquisition of Versum Materials. Next year, one production line would be allocated to Kaohsiung and more materials would be produced in Taiwan, Merck said.
Merck said it is also developing new directed self-assembly material for 3-nanometer technology and even more advanced technologies.
Merck operates fabs and labs in 10 locations in Taiwan, including Hsinchu, Taichung, Tainan and Kaohsiung, with a workforce of 1,000.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained